EGFR and neoplasm: Herein, we sought to assess the anti-proliferative, pro-apoptotic and anti-tumor activities of metapristone, a predominant metabolite of miferistone, against NSCLC cells with wild type EGFR (A549) or mutant type EGFR (H1975) both in vitro and in vivo.